Vaccine Prevention of Herpes Zoster in Organ Transplant Recipients: A Busy Intersection of Immune Responses to Foreign Antigens

Affiliations

Comment

Geraldine Miller. Clin Infect Dis. 2020.

. 2020 Jan 2;70(2):191-192.

doi: 10.1093/cid/ciz179.

¹ Vanderbilt University School of Medicine, Division of Infectious Diseases, Medical Center North, Nashville, Tennessee.

No abstract available

Keywords: herpes zoster; immunosuppression; organ transplantation; recombinant vaccine; vaccine.

Comment on

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial.
Vink P, Ramon Torrell JM, Sanchez Fructuoso A, Kim SJ, Kim SI, Zaltzman J, Ortiz F, Campistol Plana JM, Fernandez Rodriguez AM, Rebollo Rodrigo H, Campins Marti M, Perez R, González Roncero FM, Kumar D, Chiang YJ, Doucette K, Pipeleers L, Agüera Morales ML, Rodriguez-Ferrero ML, Secchi A, McNeil SA, Campora L, Di Paolo E, El Idrissi M, López-Fauqued M, Salaun B, Heineman TC, Oostvogels L; Z-041 Study Group. Vink P, et al. Clin Infect Dis. 2020 Jan 2;70(2):181-190. doi: 10.1093/cid/ciz177. Clin Infect Dis. 2020. PMID: 30843046 Free PMC article. Clinical Trial.